Avelos Therapeutics Inc. announced that it has raised $8 million in a round of funding on August 22, 2022. The Transaction included the participation from SV Investment Corporation, UTC Investment Co., Ltd., Quad Investment Management Corp., Mirae Asset Venture Investment Co., Ltd., Mirae Asset Capital Co,Ltd., Investment Arm and Timepolio Asset Management.
Mirae Asset Venture Investment Co., Ltd.
Equities
A100790
KR7100790005
Investment Management & Fund Operators
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5,610 KRW | -2.43% | -3.44% | -2.94% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.94% | 217M | |
+18.06% | 3.15B | |
+12.82% | 1.77B | |
+13.36% | 1.6B | |
-11.54% | 1.21B | |
+23.02% | 816M | |
+6.98% | 648M | |
+36.04% | 572M | |
+35.87% | 496M | |
-4.17% | 508M |
- Stock Market
- Equities
- A100790 Stock
- News Mirae Asset Venture Investment Co., Ltd.
- Avelos Therapeutics Inc. announced that it has received $8 million in funding from UTC Investment Co., Ltd., Mirae Asset Venture Investment Co., Ltd., SV Investment Corporation, Quad Investment Management Corp., Mirae Asset Capital Co,Ltd., Investment Arm